Article info

Download PDFPDF

Original research
Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial

Authors

  1. Correspondence to Dr Rene D R Oliveira; renedroliveira{at}gmail.com
View Full Text

Citation

Lopes MI, Bonjorno LP, Giannini MC, et al
Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial

Publication history

  • Received September 18, 2020
  • Revision received January 15, 2021
  • Accepted January 18, 2021
  • First published February 4, 2021.
Online issue publication 
February 04, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Press release

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.